Fire Fox, those numbers are from the trial data reported in Sept. That is a good point to make about the patients in the 3 mg/kg arm, which we know did not change.
Don't understand why PPHM had such sick patients in both pancreatic and 2nd line nsclc. Why not have used a healthier population and demonstrate blowout results?